Abstract: A DNA coding for a fusion protein comprising a polypeptide having the antigenicity of Mycoplasma gallisepticum and a polypeptide derived from Herpesvirus outer membrane protein, in which the polypeptide derived from the outer membrane protein has been ligated with the polypeptide having the antigenicity of Mycoplasma gallisepticum at the N terminus thereof, is prepared. The DNA is inserted into a region non-essential to growth of Avipox virus and the resulting recombinant Avipox virus is provided as a more potent recombinant virus as an anti-Mycoplasma vaccine.

Abstract: A method for producing a saponified ethylene-vinyl acetate copolymer which comprises saponifying an ethylene-vinyl acetate copolymer in an alcohol-based solvent with an alkali catalyst, wherein an amount between 100 ppm and 15,000 ppm of water with respect to the ethylene-vinyl acetate copolymer is supplied into the alcohol-based solvent. According to this method, discoloration, etc. of a saponified ethylene-vinyl acetate copolymer is inhibited, and visual characteristics of the saponified copolymer are improved.

Abstract: A method for processing a solution of ethylene-vinyl alcohol copolymer in a solvent other than water, which involves continuously substituting a part of the solvent in the solution with water to produce a high-concentration ethylene vinyl alcohol copolymer solution without gelling, whereby an ethylene-vinyl alcohol copolymer solution is fed into a column vessel selected from a plate column and a packed column, and a part of the solvent in the solution is substituted with water in the column vessel.

Abstract: The present invention provides methods for producing an ethylene-vinyl acetate copolymer and a saponified product thereof, in which defective appearances at the time of molding (e.g. fish eye or coloring) can be inhibited while using a recovered solvent. In the present invention, a recovered alcohol-based solvent is supplied for reuse after decreasing the concentration of an aldehyde compound contained in the solvent. The concentration of an aldehyde compound can be decreased by acetalizing it with an acid such as a cation exchange resin. For example, the concentration of an aldehyde compound in the solvent is not more than 100 ppm, and the concentration of an acetal compound in the solvent is at least 0.1 ppm but not more than 10,000 ppm.

Abstract: A method for producing a saponified ethylene-vinyl acetate copolymer, which comprises washing chips of a saponified ethylene-vinyl acetate copolymer. In this method, the chips containing impurities and methanol are introduced into a washing column through an upper portion thereof; water is introduced into the washing column through a lower portion thereof; while the methanol concentration in the solution in the upper portion of the column is maintained in the range of 25 to 45 wt % and the chips are allowed to fall (i.e. sink) from the upper portion of the column, methanol and water with at least a part of the impurities are discharged from the column through an upper portion thereof; and the chips are taken out of the column through a lower portion thereof with water that contains methanol in a lower concentration than the methanol concentration in the solution in the upper portion of the column.

Abstract: A nucleotide sequence encoding the gp82 polypeptide of Marek's disease virus is disclosed. Also disclosed are recombinant viruses which are useful as vaccines for protecting against Marek's Disease, preferably containing two more genes encoding Marek's Disease Virus antigens such as glyprotein B and glycoprotein gp82, under the control of a poxvirus promoter within a region of the DNA of fowlpox virus which is not essential for virus growth. Also provided is a vaccine exhibiting a synergistic immunoprotective effect, comprising a recombinant fowlpox virus expressing Marek's Disease Virus gB protein in combination with turkey herpesvirus. A method of immunizing poultry, comprising administering any of the disclosed vaccines, is also provided.

Abstract: A method for producing a saponified ethylene-vinyl acetate copolymer, which comprises washing chips of a saponified ethylene-vinyl acetate copolymer. In this method, the chips containing impurities and methanol are introduced into a washing column through an upper portion thereof; water is introduced into the washing column through a lower portion thereof; while the methanol concentration in the solution in the upper portion of the column is maintained in the range of 25 to 45 wt % and the chips are allowed to fall (i.e. sink) from the upper portion of the column, methanol and water with at least a part of the impurities are discharged from the column through an upper portion thereof; and the chips are taken out of the column through a lower portion thereof with water that contains methanol in a lower concentration than the methanol concentration in the solution in the upper portion of the column.

Abstract: A method for producing a saponified ethylene-vinyl acetate copolymer which comprises saponifying an ethylene-vinyl acetate copolymer in an alcohol-based solvent with an alkali catalyst, wherein an amount between 100 ppm and 15,000 ppm of water with respect to the ethylene-vinyl acetate copolymer is supplied into the alcohol-based solvent. According to this method, discoloration, etc. of a saponified ethylene-vinyl acetate copolymer is inhibited, and visual characteristics of the saponified copolymer are improved.

Abstract: The present invention provides methods for producing an ethylene-vinyl acetate copolymer and a saponified product thereof, in which defective appearances at the time of molding (e.g. fish eye or coloring) can be inhibited while using a recovered solvent. In the present invention, a recovered alcohol-based solvent is supplied for reuse after decreasing the concentration of an aldehyde compound contained in the solvent. The concentration of an aldehyde compound can be decreased by acetalizing it with an acid such as a cation exchange resin. For example, the concentration of an aldehyde compound in the solvent is not more than 100 ppm, and the concentration of an acetal compound in the solvent is at least 0.1 ppm but not more than 10,000 ppm.

Abstract: A method for processing a solution of ethylene-vinyl alcohol copolymer in a solvent other than water, which involves continuously substituting a part of the solvent in the solution with water to produce a high-concentration ethylene vinyl alcohol copolymer solution without gelling, whereby an ethylene-vinyl alcohol copolymer solution is fed into a column vessel selected from a plate column and a packed column, and a part of the solvent in the solution is substituted with water in the column vessel.

Abstract: A nucleotide sequence encoding the gp82 polypeptide of Marek's disease virus is disclosed. Also disclosed are recombinant viruses which are useful as vaccines for protecting against Marek's Disease, preferably containing two or more genes encoding Marek's Disease Virus antigens such as glycoprotein B and glycoprotein gp82, under the control of a poxvirus promoter within a region of the DNA of fowlpox virus which is not essential for virus growth. Also provided is a vaccine exhibiting a synergistic immunoprotective effect, comprising a recombinant fowlpox virus expressing Marek's Disease Virus gB protein in combination with turkey herpesvirus. A method of immunizing poultry, comprising administering any of the disclosed vaccines, is also provided.

Abstract: A DNA coding for a fusion protein comprising a polypeptide having the antigenicity of Mycoplasma gallisepticum and a polypeptide derived from Herpesvirus outer membrane protein, in which the polypeptide derived from the outer membrane protein has been ligated with the polypeptide having the antigenicity of Mycoplasma gallisepticum at the N terminus thereof, is prepared. The DNA is inserted into a region non-essential to growth of Avipox virus and the resulting recombinant Avipox virus is provided as a more potent recombinant virus as an anti-Mycoplasma vaccine.

Abstract: A polymerized toner of core-shell structure, comprising core particles composed of colored polymer particles which contain a compound having at least one >C═N+< structure in its molecule and a colorant, and a layer of a polymer having a glass transition temperature higher than that of a polymer component making up the core particles, said polymer layer covering each of the core particles, a production process thereof, an image forming process comprising using the polymerized toner, and an image forming apparatus containing the polymerized toner.

Abstract: A polymerized toner of core-shell structure, comprising core particles composed of colored polymer particles, which comprise a polyfunctional ester compound formed of a trifunctional or still higher polyfunctional polyhydric alcohol and a carboxylic acid, and a colorant, and shell which is formed of a polymer having a glass transition temperature higher than that of a polymer component making up the core particles and covers each of the core particles, a production process thereof, an image forming process comprising using the polymerized toner, and an image forming apparatus containing the polymerized toner.

Abstract: Disclosed herein are a polymerized toner of core-shell structure, comprising core particles composed of colored polymer particles having a volume average particle diameter (dv) of 0.5-20 .mu.m and a ratio (dv/dp) of the volume average particle diameter (dv) to a number average particle diameter (dp) of at most 1.7, and shell which is formed of a polymer layer having an average film thickness of 0.001-0.1 .mu.m and covers each of the core particles, and a production process thereof.

Abstract: Disclosed herein are a polymerized toner of core-shell structure, comprising core particles composed of colored polymer particles having a volume average particle diameter (dv) of 0.5-20 .mu.m and a ratio (dv/dp) of the volume average particle diameter (dv) to a number average particle diameter (dp) of at most 1.7, and shell which is formed of a polymer layer having an average film thickness of 0.001-0.1 .mu.m and covers each of the core particles, and a production process thereof.

Abstract: Antigen proteins of Mycoplasma gallisepticum, genes encoding the antigen protein, recombinant vectors integrated with the gene and hosts transformed with the vector are provided. Diagnostics and vaccine using the antigen protein produced by such hosts are effective for poultry, especially chicken infected with Mycoplasma gallisepticum. Vaccination can maintain poultry free of Mycoplasma gallisepticum infection.

Abstract: Antigen proteins of Mycoplasma gallisepticum, genes encoding the antigen protein, recombinant vectors integrated with the gene and hosts transformed with the vector are provided. Diagnostics and vaccine using the antigen protein produced by such hosts are effective for poultry, especially chicken infected with Mycoplasma gallisepticum. Vaccination can maintain poultry free of Mycoplasma gallisepticum infection.

Abstract: A recombinant fowlpox virus is provided which is useful as a vaccine for protection against avian reticuloendo-theliosis virus-associated diseases. In a specific embodiment, the recombinant virus expresses a gene encoding an envelope glycoprotein of spleen necrosis virus under the control of a poxvirus promoter, inserted in a nonessential region of the fowlpox virus genome.

Abstract: A recombinant Avipoxvirus having inserted exogenous DNA in a DNA region non-essential to proliferation of Avipoxvirus is provided. The recombinant Avipoxvirus is produced by inserting a promoter and exogenous DNA capable of expression under its control into a DNA region non-essential to proliferation of Avipoxvirus, utilizing DNA coding for a readily detectable enzyme, or, non-homologous DNA fragment.